United States  

Celebrating 10 Years of Trusted News Discovery
One News Page
> > >

FDA finds small amounts of probable carcinogen in Zantac and other heartburn drugs

USATODAY.com Friday, 13 September 2019 ()
The FDA tested ranitidine heartburn medications and found small amounts of a probable carcinogen. The agency has not recommended the drugs be recalled
0
shares
ShareTweetSavePostSend
 
Credit: Rumble - Published < > Embed
News video: FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs

FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs 00:58

​The FDA says Zantac-brand heartburn medicines contain small amounts of a known &quot;probable carcinogen.&quot;

You Might Like


Recent related news from verified sources

Novartis has halted distribution of generic Zantac. Here's what you need to know.

A version of a popular heartburn medicine is now on hold. There are concerns that the generic version of the drug known as Zantac may cause cancer. Novartis...
CBS News

FDA finds cancer-causing chemical in heartburn medicine Zantac

Small amounts of a cancer-causing chemical have been found in the popular heartburn medication Zantac, as well is in generic forms of the drug, known as...
CBS News

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.